6I8A image
Deposition Date 2018-11-19
Release Date 2019-01-30
Last Version Date 2024-01-24
Entry Detail
PDB ID:
6I8A
Title:
The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.27
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
P 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA polymerase epsilon catalytic subunit A
Gene (Uniprot):POL2
Mutagens:P301R
Chain IDs:A, D (auth: B)
Chain Length:1190
Number of Molecules:2
Biological Source:Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Polymer Type:polydeoxyribonucleotide
Molecule:Primer DNA
Chain IDs:B (auth: P), E (auth: C)
Chain Length:11
Number of Molecules:2
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:Template DNA
Chain IDs:C (auth: T), F (auth: D)
Chain Length:16
Number of Molecules:2
Biological Source:synthetic construct
Primary Citation
Structural consequence of the most frequently recurring cancer-associated substitution in DNA polymerase epsilon.
Nat Commun 10 373 373 (2019)
PMID: 30670696 DOI: 10.1038/s41467-018-08114-9

Abstact

The most frequently recurring cancer-associated DNA polymerase ε (Pol ε) mutation is a P286R substitution in the exonuclease domain. While originally proposed to increase genome instability by disrupting exonucleolytic proofreading, the P286R variant was later found to be significantly more pathogenic than Pol ε proofreading deficiency per se. The mechanisms underlying its stronger impact remained unclear. Here we report the crystal structure of the yeast orthologue, Pol ε-P301R, complexed with DNA and an incoming dNTP. Structural changes in the protein are confined to the exonuclease domain, with R301 pointing towards the exonuclease site. Molecular dynamics simulations suggest that R301 interferes with DNA binding to the exonuclease site, an outcome not observed with the exonuclease-inactive Pol ε-D290A,E292A variant lacking the catalytic residues. These results reveal a distinct mechanism of exonuclease inactivation by the P301R substitution and a likely basis for its dramatically higher mutagenic and tumorigenic effects.

Legend

Protein

Chemical

Disease

Primary Citation of related structures